| A malignant
tumour characterised by the uncontrolled growth and spread of malignant
cells and the invasion of tissue to any of the following sites: breast,
cervix uteri, uterus, ovary, fallopian tube, vagina and vulva.
This excludes secondary cancer, which has
originated from other organs and spread to the female genital tract and
breast, non-invasive cancer-in-situ, and tumours in the presence of any
Human Immunodeficiency Virus (HIV).
Diagnosis must be supported by
histological evidence of malignancy.
A waiting period of sixty (60) days is
applicable to this benefit. |